> top > docs > PMC:7195088 > spans > 26137-29724 > annotations

PMC:7195088 / 26137-29724 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T26 2932-2938 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T27 3198-3201 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873
T28 3260-3263 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T20 2389-2394 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542
T21 2876-2881 Body_part denotes Scale http://purl.obolibrary.org/obo/UBERON_0002542
T22 3571-3576 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T129 408-416 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T130 527-535 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T131 637-645 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T132 794-802 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T133 1072-1080 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T134 1150-1158 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T135 1270-1278 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T136 1426-1434 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T137 1475-1483 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T138 1665-1673 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T139 1789-1797 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T140 1923-1931 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T141 2047-2055 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T142 2058-2067 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T143 2154-2162 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T144 2306-2314 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T145 2512-2520 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T146 2754-2762 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T147 2850-2858 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T148 3052-3060 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T149 3202-3210 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T150 3452-3460 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T136 127-128 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T137 201-206 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T138 281-282 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T139 343-344 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T140 809-814 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T141 874-875 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T142 921-922 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T143 1087-1092 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T144 1183-1188 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T145 1405-1406 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T146 1446-1448 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T147 1458-1459 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T148 1495-1497 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T149 1540-1542 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T150 1585-1587 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T151 2017-2018 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T152 2278-2279 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T153 2349-2350 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T154 2371-2374 http://purl.obolibrary.org/obo/CLO_0001577 denotes a 3
T155 2527-2532 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T156 2932-2938 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T157 3067-3072 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T158 3132-3133 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T159 3145-3150 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T160 3185-3186 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T161 3553-3556 http://purl.obolibrary.org/obo/CLO_0001608 denotes a 7

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T352 26-44 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T353 201-206 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T354 475-493 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T355 498-511 Chemical denotes ascorbic acid http://purl.obolibrary.org/obo/CHEBI_22652|http://purl.obolibrary.org/obo/CHEBI_29073
T357 507-511 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T358 683-694 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T359 700-718 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T360 724-736 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T361 741-752 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T362 758-776 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T363 809-814 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T364 1020-1038 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T365 1087-1092 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T366 1222-1240 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T367 1321-1331 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T368 1612-1630 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T369 1858-1877 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T370 1858-1867 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T371 1868-1877 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T372 2108-2126 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T373 2422-2432 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T374 2437-2455 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T375 2460-2470 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T376 2476-2494 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T377 2527-2532 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T378 2668-2687 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T379 2668-2677 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T380 2678-2687 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T381 2692-2710 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T382 2715-2723 Chemical denotes losartan http://purl.obolibrary.org/obo/CHEBI_6541
T383 2944-2962 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T384 2968-2980 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T385 2985-3003 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T386 3009-3021 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T387 3067-3072 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T388 3308-3327 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T389 3308-3317 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T390 3318-3327 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T391 3332-3350 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T392 3355-3374 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T393 3355-3364 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T394 3365-3374 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T395 3380-3390 Chemical denotes interferon http://purl.obolibrary.org/obo/CHEBI_52999
T396 3391-3395 Chemical denotes beta http://purl.obolibrary.org/obo/CHEBI_10545
T397 3403-3413 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T194 136-260 Sentence denotes Double-blind RCT for outpatients and healthcare workers and open-label RCT for inpatients (NCT04329923, not yet recruiting).
T195 261-458 Sentence denotes Primary endpoints: (a) release from quarantine (outpatients, follow-up 14 days); (b) discharge (inpatients, follow-up 14 days); (c) development of COVID-19 (healthcare workers, follow-up 2 months).
T196 459-545 Sentence denotes • Comparison of hydroxychloroquine vs. ascorbic acid in contacts of COVID-19 patients.
T197 546-597 Sentence denotes Double-blind RCT (NCT04328961, not yet recruiting).
T198 598-666 Sentence denotes Primary endpoint: laboratory-confirmed COVID-19 (follow-up 14 days).
T199 667-803 Sentence denotes • Comparison of tocilizumab plus hydroxychloroquine plus azithromycin vs. tocilizumab plus hydroxychloroquine in patients with COVID-19.
T200 804-853 Sentence denotes Open-label RCT (NCT04332094, not yet recruiting).
T201 854-1081 Sentence denotes Primary endpoints: (a) in-hospital mortality (follow-up 2 weeks); (b) need for mechanical ventilation in the ICU (follow-up 2 weeks).• Comparison of ciclesonide plus hydroxychloroquine vs. ciclesonide in patients with COVID-19.
T202 1082-1131 Sentence denotes Open-label RCT (NCT04330586, not yet recruiting).
T203 1132-1205 Sentence denotes Primary endpoint: SARS-CoV-2 eradication (based on virus load) at day 14.
T204 1206-1332 Sentence denotes • Comparison of hydroxychloroquine vs. placebo in patients with COVID-19 and under biological treatment and/or JAK inhibitors.
T205 1333-1384 Sentence denotes Double-blind RCT (NCT04330495, not yet recruiting).
T206 1385-1595 Sentence denotes Primary endpoints: (a) incidence rate of COVID-19 (follow-up 27 weeks); (b) prevalence of COVID-19 (follow-up 27 weeks); (c) case fatality rate (follow-up 27 weeks); (d) ICU admission rate (follow-up 27 weeks).
T207 1596-1704 Sentence denotes • Comparison of hydroxychloroquine vs. placebo for the prevention of COVID-19 in healthcare workers at risk.
T208 1705-1756 Sentence denotes Double-blind RCT (NCT04328467, not yet recruiting).
T209 1757-1819 Sentence denotes Primary endpoint: prevalence of COVID-19 (follow-up 12 weeks).
T210 1820-1932 Sentence denotes • Comparison of chemoprophylaxis with lopinavir/ritonavir vs. placebo in healthcare workers exposed to COVID-19.
T211 1933-1984 Sentence denotes Double-blind RCT (NCT04328285, not yet recruiting).
T212 1985-2002 Sentence denotes Primary endpoint:
T213 2003-2091 Sentence denotes Occurrence of a symptomatic or asymptomatic SARS-CoV-2 infection (follow-up 2.5 months).
T214 2092-2213 Sentence denotes • Comparison of hydroxychloroquine vs. placebo in symptomatic COVID-19 patients or exposed healthcare workers/households.
T215 2214-2257 Sentence denotes Double-blind RCT (NCT04308668, recruiting).
T216 2258-2405 Sentence denotes Primary endpoints: (a) incidence of symptomatic COVID-19 among asymptomatic participants; (b) severity rating on a 3-point ordinal scale at day 14.
T217 2406-2521 Sentence denotes • Comparison of remdesivir vs. hydroxychloroquine vs. remdesivir plus hydroxychloroquine in patients with COVID-19.
T218 2522-2580 Sentence denotes Open-label adaptive RCT (NCT04321616, not yet recruiting).
T219 2581-2651 Sentence denotes Primary endpoint: all-cause in-hospital mortality (follow-up 3 weeks).
T220 2652-2763 Sentence denotes • Comparison of lopinavir/ritonavir vs. hydroxychloroquine vs. losartan vs. placebos in patients with COVID-19.
T221 2764-2825 Sentence denotes Double-blind, adaptive RCT (NCT04328012, not yet recruiting).
T222 2826-2902 Sentence denotes Primary endpoint: NIAID COVID-19 Ordinal Severity Scale (follow-up 60 days).
T223 2903-3061 Sentence denotes • Comparison of convalescent plasma plus hydroxychloroquine plus azithromycin vs. hydroxychloroquine plus azithromycin in hospitalized patients with COVID-19.
T224 3062-3111 Sentence denotes Open-label RCT (NCT04332835, not yet recruiting).
T225 3112-3291 Sentence denotes Primary endpoints: (a) change in virus load at days 0, 4, 7, 14 and 28; (b) change in IgM COVID-19 titers at days 0, 4, 7, 14 and 28; (c) change in IgG at days 0, 4, 7, 14 and 28.
T226 3292-3461 Sentence denotes • Comparison of lopinavir/ritonavir vs. hydroxychloroquine vs. lopinavir/ritonavir plus interferon beta-1a vs. remdesivir vs. standard of care in patients with COVID-19.
T227 3462-3515 Sentence denotes Double-blind, adaptive RCT (NCT04315948, recruiting).
T228 3516-3587 Sentence denotes Primary endpoint: severity rating on a 7-point ordinal scale at day 15.